tirzepatide approval for weight loss (ZEPBOUND) Approved Chronic Management in Adults with Obesity ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Lilly Rises on FDA Approval

As the number of GLP-1 options grew, Novo Nordisk and Lilly invested heavily in promotional campaigns

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

The bacterium maintains mucosal homeostasis via specialized mucinolytic enzymes while secreting functionally diverse components including SCFAs, outer membrane proteins (notably Amuc_1100), and extracellular vesicles (EVs)

Board-certified psychiatric providers offering virtual mental health care, ADHD treatment, medication management, and weight loss programs.

Those who discontinued had an increased risk of heart attack and stroke compared to those who remained on treatment.

Find out more about its usage, effectiveness, and how it works.